Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCX
· Real-Time Price · USD
1.10
0.01 (0.92%)
At close: May 23, 2025, 3:59 PM
1.10
0.00%
After-hours: May 23, 2025, 05:04 PM EDT
0.92% (1D)
| Bid | 1.04 |
| Market Cap | 50.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -60.71M |
| EPS (ttm) | -1.39 |
| PE Ratio (ttm) | -0.79 |
| Forward PE | -1.51 |
| Analyst | Buy |
| Ask | 1.13 |
| Volume | 154,277 |
| Avg. Volume (20D) | 278,273 |
| Open | 1.09 |
| Previous Close | 1.09 |
| Day's Range | 1.04 - 1.14 |
| 52-Week Range | 0.51 - 2.45 |
| Beta | 0.83 |
About QNCX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNCX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for QNCX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+19.5%
Quince Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
6 months ago
+19%
Quince Therapeutics shares are trading higher after Rodman & Renshaw initiated coverage on the stock with a Buy rating and announced an $11 price target.
3 weeks ago · businesswire.com
Quince Therapeutics to Present at Citizens Life Sciences ConferenceSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biolog...
